Compare ELVN & CFFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ELVN | CFFN |
|---|---|---|
| Founded | 2016 | 1893 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 905.3M |
| IPO Year | 2020 | 1999 |
| Metric | ELVN | CFFN |
|---|---|---|
| Price | $17.85 | $7.11 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 2 |
| Target Price | ★ $41.20 | $6.75 |
| AVG Volume (30 Days) | 809.4K | ★ 1.0M |
| Earning Date | 11-12-2025 | 01-28-2026 |
| Dividend Yield | N/A | ★ 4.74% |
| EPS Growth | N/A | ★ 79.31 |
| EPS | N/A | ★ 0.52 |
| Revenue | N/A | ★ $200,291,000.00 |
| Revenue This Year | N/A | $16.44 |
| Revenue Next Year | N/A | $3.40 |
| P/E Ratio | ★ N/A | $13.81 |
| Revenue Growth | N/A | ★ 20.62 |
| 52 Week Low | $13.30 | $4.90 |
| 52 Week High | $25.37 | $7.31 |
| Indicator | ELVN | CFFN |
|---|---|---|
| Relative Strength Index (RSI) | 42.75 | 64.71 |
| Support Level | $15.71 | $6.93 |
| Resistance Level | $17.58 | $7.31 |
| Average True Range (ATR) | 1.41 | 0.13 |
| MACD | -0.30 | 0.02 |
| Stochastic Oscillator | 32.86 | 67.97 |
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
Capitol Federal Financial Inc is a bank holding company that operates through its wholly-owned subsidiary bank. The bank is a community-oriented financial institution that offers a variety of financial services through tens of locations. It mainly serves metropolitan areas within the state of Kansas. The bank performs traditional banking functions such as deposit-taking activities and investing that money in first-lien residential mortgages. It also participates in commercial real estate loans with other lenders, investing those funds in various securities. The vast majority of the bank's loan portfolio is in originated one- to four-family real estate loans. Its primary source of income is net interest income.